2023
Role of PET/CT in Oropharyngeal Cancers
Avery E, Joshi K, Mehra S, Mahajan A. Role of PET/CT in Oropharyngeal Cancers. Cancers 2023, 15: 2651. PMID: 37174116, PMCID: PMC10177278, DOI: 10.3390/cancers15092651.Peer-Reviewed Original Research
2018
A case of pediatric cervicofacial actinomyces masquerading as malignancy: Case report and review of the literature
Savoca E, Mehra S, Waldman EH. A case of pediatric cervicofacial actinomyces masquerading as malignancy: Case report and review of the literature. International Journal Of Pediatric Otorhinolaryngology 2018, 116: 204-208. PMID: 30554700, DOI: 10.1016/j.ijporl.2018.11.001.Peer-Reviewed Original ResearchConceptsAnterior neck massProlonged antibiotic courseFine needle aspiratesSix-week courseAntibiotic coursesOral penicillinSurgical debridementParenteral penicillinUncommon infectionMalignant appearanceNeck massOpen biopsyCase reportNeedle biopsyCulture sensitivityNeedle aspiratesBiopsyConvalescent therapyActinomycesDiagnosisPenicillinCase discussionDebridementPatientsMalignancy
2017
Treatment delays in oral cavity squamous cell carcinoma and association with survival
Fujiwara RJ, Judson BL, Yarbrough WG, Husain Z, Mehra S. Treatment delays in oral cavity squamous cell carcinoma and association with survival. Head & Neck 2017, 39: 639-646. PMID: 28236349, DOI: 10.1002/hed.24608.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCarcinoma, Squamous CellCause of DeathChemoradiotherapy, AdjuvantCohort StudiesCombined Modality TherapyDatabases, FactualDisease-Free SurvivalFemaleHead and Neck NeoplasmsHumansKaplan-Meier EstimateMaleMiddle AgedMouth NeoplasmsNeoplasm InvasivenessNeoplasm StagingPredictive Value of TestsPrognosisProportional Hazards ModelsRetrospective StudiesRisk AssessmentSquamous Cell Carcinoma of Head and NeckSurvival AnalysisTime-to-TreatmentUnited StatesConceptsSquamous cell carcinomaOral cavity squamous cell carcinomaNational Cancer Data BaseOverall survivalRT durationTotal treatment packageCox proportional hazards modelDecreased overall survivalProportional hazards modelTreatment packageBinary logistic regressionMedicaid insuranceTreatment delayCell carcinomaAcademic/research institutionsHazards modelLate PTSurgery delayTreatment durationRadiotherapySurgeryLogistic regressionDiagnosisDurationImpact of delay